The Global Microfluidics Market size is
estimated to reach US$58.5 billion by 2030, growing at a CAGR of 12.5% from 2023
to 2030. Significant demand for low-volume sample analysis, growing demand for
point-of-care testing devices and the emergence of microfluidics-based 3D cell
culture systems are propelling the growth of the Microfluidics industry. In November
2021, Fluidigm launched a new Biomark X microfluidics platform. Biomark X
simplifies workflows, streamlines operations to reduce hands-on time and
accelerates results. However, the complex and time-consuming regulatory process is
hampering the growth of the Microfluidics market during the forecast period.
Moreover, technological advancements and growing demand for miniaturized integrated microfluidic medical devices are creating ample opportunities for the Microfluidics Market to grow. In May 2022, Xidas introduced ‘Pascal’ which is the first smart microfluidics in-line pressure sensor in the industry. These micro pressure sensors are the first in a series of the world’s most highly integrated microfluidic devices, based on Xidas’s 3D heterogeneous integration platform.
APAC generated approximately 19% of the global revenues in the Microfluidics industry in 2022 and it is expected to grow at the highest CAGR of 13.8% during the forecast period. The growing prevalence of various chronic diseases, rapidly increasing population and rising investment in R&D activities by governments and private organizations are driving the market growth in this region. In August 2022, HORIBA announced a collaboration with SigTuple to speed up the deployment of its AI100. SigTuple combined AI, robotics, microfluidics and cloud computing to develop smart diagnostic solutions to make quality healthcare delivery accessible and affordable and thereby increase the Microfluidics Market size.
Microfluidics Market Growth Driver:
Emergence of microfluidics-based 3D cell culture systems:
The increasing applications of microfluidics in 3D cell culture systems would offer an array of opportunities for market growth. Technological advancements have enabled the use of microfluidics in 3D cell culture to develop microenvironments that support tissue differentiation and replicate the tissue-tissue interface, spatiotemporal chemical gradients and mechanical environments for living organs. Microfluidics-based 3D cell cultures also show a higher degree of structural complexity and retain homeostasis for a longer period. The 3D cell cultures are predominantly used in vaccine development, especially in the pandemic-driven period. In July 2021, Amerigo Scientific launched its 3D cell cultures bioreactor, which would allow for rapid cell colonization in an in-vitro study. Moreover, it would also allow for the development of an in-vivo-like microenvironment. It allows for greater predictivity and enhanced efficiency of toxicity. These factors would positively influence the Microfluidics industry outlook during the forecast period.
Major Players in this Market
The major players in Microfluidics Market include Samsung Electronics, LG Microfluidics, Sharp, Panasonic, NEC Corporation and BOE Technology among others. In August 2022, associates at the School of Electrical and Computer Engineering, Atlanta, developed the Cluster-Well chip, which leveraged the precision of Microfluidic chips to detect metastatic cancer and enable quick and easy treatment of cancer.